These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 23003207)

  • 1. Surreptitious antiretroviral use as an explanation for apparent elite HIV control.
    Costiniuk CT; La Porte CJ; Angel JB
    AIDS Patient Care STDS; 2012 Nov; 26(11):645-6. PubMed ID: 23003207
    [No Abstract]   [Full Text] [Related]  

  • 2. Microbial translocation predicts disease progression of HIV-infected antiretroviral-naive patients with high CD4+ cell count.
    Marchetti G; Cozzi-Lepri A; Merlini E; Bellistrì GM; Castagna A; Galli M; Verucchi G; Antinori A; Costantini A; Giacometti A; di Caro A; D'arminio Monforte A;
    AIDS; 2011 Jul; 25(11):1385-94. PubMed ID: 21505312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A nursing consultation to improve antiretroviral medication management in children].
    Vaudre G; Dollfus C; Tabone MD; Courcoux MF; Portier E; Leverger G
    Soins Pediatr Pueric; 2010; (256):35-8. PubMed ID: 20925307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-1 control after transient antiretroviral treatment initiated in primary infection: role of patient characteristics and effect of therapy.
    Goujard C; Girault I; Rouzioux C; Lécuroux C; Deveau C; Chaix ML; Jacomet C; Talamali A; Delfraissy JF; Venet A; Meyer L; Sinet M;
    Antivir Ther; 2012; 17(6):1001-9. PubMed ID: 22865544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. British HIV Association guidelines for antiretroviral treatment of HIV seropositive individuals.
    Carey PB; Lloyd J; Timmins D
    Lancet; 1997 Jun; 349(9068):1837. PubMed ID: 9269231
    [No Abstract]   [Full Text] [Related]  

  • 6. HIV/HCV coinfection: refining or redefining concepts?
    Peribañez Gonzalez M; Guimarães Pessôa M
    Liver Int; 2007 Feb; 27(1):1-3. PubMed ID: 17241374
    [No Abstract]   [Full Text] [Related]  

  • 7. HIV-1 viral rebound dynamics after a single treatment interruption depends on time of initiation of highly active antiretroviral therapy.
    Steingrover R; Pogány K; Fernandez Garcia E; Jurriaans S; Brinkman K; Schuitemaker H; Miedema F; Lange JM; Prins JM
    AIDS; 2008 Aug; 22(13):1583-8. PubMed ID: 18670217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune and virological benefits of 10 years of permanent viral control with antiretroviral therapy.
    Guihot A; Tubiana R; Breton G; Marcelin AG; Samri A; Assoumou L; Goncalves E; Bricaire F; Costagliola D; Calvez V; Rouzioux C; Autran B; Katlama C; Carcelain G; ;
    AIDS; 2010 Feb; 24(4):614-7. PubMed ID: 19952710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of highly active anti-retroviral therapy on CD3+/CD4+/CD8+ T lymphocyte counts in HIV seropositive Kashmiri patients: a follow up study.
    Shah ZA; Rasool R; Siddiqi MA
    Indian J Pathol Microbiol; 2007 Jul; 50(3):648-51. PubMed ID: 17883172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of "HAART" on CD4+ T lymphocyte counts in HIV seropositive south-Indian individuals--a follow up study.
    Shahapur PR; Bairy I; Shivananda PG
    Indian J Pathol Microbiol; 2005 Apr; 48(2):270-2. PubMed ID: 16758693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV neutralizing antibody titer during structured treatment interruption of highly active antiretroviral therapy.
    Nicastri E; Dori L; Buonomini AR; Tommasi C; De Nardo P; Bellagamba R; Corpolongo A; Montano M; Sordillo P; Volpi A; Sarmati L; Andreoni M
    AIDS; 2012 Jul; 26(11):1451-2. PubMed ID: 22767346
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunological and virological effects of highly active antiretroviral therapy in two HIV-1 infected children.
    Leon JA; Leal M; Lissen E; Gurbindo D; Muñoz-Fernández MA
    Acta Paediatr; 2000 Mar; 89(3):373-4. PubMed ID: 10772297
    [No Abstract]   [Full Text] [Related]  

  • 13. Non-B HIV type 1 subtypes: replicative capacity and response to antiretroviral therapy.
    Nicastri E; Sarmati L; d'Ettorre G; Parisi SG; Palmisano L; Montano M; Buonomini AR; Galluzzo C; Vullo V; Concia E; Vella S; Andreoni M
    AIDS Res Hum Retroviruses; 2004 Aug; 20(8):816-8. PubMed ID: 15320985
    [No Abstract]   [Full Text] [Related]  

  • 14. Progressive multifocal leukoencephalopathy following initiation of highly active antiretroviral therapy.
    Mayo J; Collazos J; Martínez E
    AIDS; 1998 Sep; 12(13):1720-2. PubMed ID: 9764796
    [No Abstract]   [Full Text] [Related]  

  • 15. Suppression of human immunodeficiency virus type 1 viral load with selenium supplementation: a randomized controlled trial.
    Hurwitz BE; Klaus JR; Llabre MM; Gonzalez A; Lawrence PJ; Maher KJ; Greeson JM; Baum MK; Shor-Posner G; Skyler JS; Schneiderman N
    Arch Intern Med; 2007 Jan; 167(2):148-54. PubMed ID: 17242315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulation of HIV-specific cellular immunity by structured treatment interruption fails to enhance viral control in chronic HIV infection.
    Oxenius A; Price DA; Günthard HF; Dawson SJ; Fagard C; Perrin L; Fischer M; Weber R; Plana M; García F; Hirschel B; McLean A; Phillips RE
    Proc Natl Acad Sci U S A; 2002 Oct; 99(21):13747-52. PubMed ID: 12370434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antiviral therapy of HIV infection in adults].
    Ormaasen V; Bruun JN
    Tidsskr Nor Laegeforen; 2001 Nov; 121(29):3414-20. PubMed ID: 11826789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. British HIV Association guidelines for antiretroviral treatment of HIV Seropositive individuals.
    Harindra V
    Lancet; 1997 Jun; 349(9068):1838. PubMed ID: 9269233
    [No Abstract]   [Full Text] [Related]  

  • 19. [When should antiretroviral therapy be started?].
    Meienberg F
    Praxis (Bern 1994); 2001 Aug; 90(33):1364-7. PubMed ID: 11534321
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment 2.0: catalysing the next phase of scale-up.
    Hirnschall G; Schwartländer B
    Lancet; 2011 Jul; 378(9787):209-11. PubMed ID: 21353697
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.